20. Pang CS, Shen YC, Tian PW, et al. Accuracy of the interferon-gamma release assay for the diagnosis of tuberculous pleurisy: an updated meta-analysis. Peer J, 2015, 3:e951.
26. Antonangelo L, Sales RK, Cora AP, et al. Pleural fluid tumour markers in malignant pleural effusion with inconclusive cytology results. Curr Oncol, 2015, 22:e336-341.
[17]
27. Sun W, Li J, Jiang HG, et al. Diagnostic value of MUC1 and EpCAM mRNA as tumor markers in differentiating benign from malignant pleural effusion. QJM, 2014, 107:1001-1007.
31. James P, Gupta R, Christopher DJ, et al. Evaluation of the diagnostic yield and safety of closed pleural biopsy in the diagnosis of pleural effusion. IndianJTuberc, 2010, 57:19-24.
28. Sriram KB, Relan V, Clarke BE, et al. Pleural fluid cell-free DNA integrity index to identify cytologically negative malignant pleural effusions including mesotheliomas. BMC Cancer, 2012, 12:1-12.
33. Pereyra MF, San-José E, Ferreiro L, et al. Role of blind closed pleural biopsy in the management of pleural exudates. Can Respir J, 2013, 20:362-366.
[40]
34. Abdullah A, Hend M, Hema R. Diagnostic yield of closed pleural biopsy in exudative pleural effusion. Saudi Med J, 2003, 24:282-286.
39. Botana-Rial M, Leiro-Fernández V, Represas-Represas C, et al. Thoracic ultrasound-assisted selection for pleural biopsy with Abrams needle. Respir Care, 2013, 58:1949-1954.
47. Emad A, Rezaian GR. Diagnostic value of closed percutaneous pleural biopsy vs pleuroscopy in suspected malignant pleural effusion or tuberculous pleurisy inaregion withahigh incidence of tuberculosis:acomparative, age-dependent study. Respir Med, 1998, 92:488-492.
[48]
48. Son HS, Lee SH, Darlong LM, et al. Is therearole foraneedle thoracoscopic pleural biopsy under local anesthesia for pleural effusions? KoreanJThorac Cardiovasc Surg, 2014, 47:124-128.